Enrique Poradosu - Net Worth and Insider Trading
Enrique Poradosu Net Worth
The estimated net worth of Enrique Poradosu is at least $13 Million dollars as of 2024-11-07. Enrique Poradosu is the Chief Science & Business Off of Nuvectis Pharma Inc and owns about 1,504,319 shares of Nuvectis Pharma Inc (NVCT) stock worth over $13 Million. Details can be seen in Enrique Poradosu's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Enrique Poradosu has not made any transactions after 2024-05-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Enrique Poradosu
Enrique Poradosu Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Enrique Poradosu owns 1 companies in total, including Nuvectis Pharma Inc (NVCT) .
Click here to see the complete history of Enrique Poradosu’s form 4 insider trades.
Insider Ownership Summary of Enrique Poradosu
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NVCT | Nuvectis Pharma Inc | 2024-05-10 | Chief Science and Business Off |
Enrique Poradosu Latest Holdings Summary
Enrique Poradosu currently owns a total of 1 stock. Enrique Poradosu owns 1,504,319 shares of Nuvectis Pharma Inc (NVCT) as of May 10, 2024, with a value of $13 Million.
Latest Holdings of Enrique Poradosu
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NVCT | Nuvectis Pharma Inc | 2024-05-10 | 1,504,319 | 8.52 | 12,819,205 |
Holding Weightings of Enrique Poradosu
Enrique Poradosu Form 4 Trading Tracker
According to the SEC Form 4 filings, Enrique Poradosu has made a total of 3 transactions in Nuvectis Pharma Inc (NVCT) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Nuvectis Pharma Inc is the acquisition of 500 shares on May 10, 2024, which cost Enrique Poradosu around $3,145.
Insider Trading History of Enrique Poradosu
- 1
Enrique Poradosu Trading Performance
GuruFocus tracks the stock performance after each of Enrique Poradosu's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Enrique Poradosu is 57.89%. GuruFocus also compares Enrique Poradosu's trading performance to market benchmark return within the same time period. The performance of stocks bought by Enrique Poradosu within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Enrique Poradosu's insider trading performs compared to the benchmark.
Performance of Enrique Poradosu
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.89 | | | | | |
| Relative Return to S&P 500(%) | 7.79 | | | | | |
Enrique Poradosu Ownership Network
Ownership Network List of Enrique Poradosu
Ownership Network Relation of Enrique Poradosu
Enrique Poradosu Owned Company Details
What does Nuvectis Pharma Inc do?
Who are the key executives at Nuvectis Pharma Inc?
Enrique Poradosu is the Chief Science and Business Off of Nuvectis Pharma Inc. Other key executives at Nuvectis Pharma Inc include director & Chairman & CEO Ron Bentsur , Chief Development Officer Shay Shemesh , and 10 percent owner Marlio Charles Mosseri .
Nuvectis Pharma Inc (NVCT) Insider Trades Summary
Over the past 18 months, Enrique Poradosu made 1 insider transaction in Nuvectis Pharma Inc (NVCT) with a net purchase of 500. Other recent insider transactions involving Nuvectis Pharma Inc (NVCT) include a net purchase of 18,095 shares made by Ron Bentsur , a net purchase of 202,124 shares made by Marlio Charles Mosseri , and a net purchase of 1,113 shares made by Shay Shemesh .
In summary, during the past 3 months, insiders sold 0 shares of Nuvectis Pharma Inc (NVCT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nuvectis Pharma Inc (NVCT) were sold and 221,832 shares were bought by its insiders, resulting in a net purchase of 221,832 shares.
Nuvectis Pharma Inc (NVCT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nuvectis Pharma Inc Insider Transactions
Enrique Poradosu Mailing Address
Above is the net worth, insider trading, and ownership report for Enrique Poradosu. You might contact Enrique Poradosu via mailing address: C/o Nuvectis Pharma, Inc., 1 Bridge Plaza, Fort Lee Nj 07024.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
